Clinical Trial Results: An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC) [Phase 3]

View source ↗

Summary

Phase 3 extension study results for maralixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Familial Intrahepatic Cholestasis

Drugs mentioned

• Maralixibat (maralixibat)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Progressive Familial Intrahepatic Cholestasis (PFIC) | Phase 3 | Status: COMPLETED | Results posted: 2026-06-23